EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.14 | L-iditol 2-dehydrogenase |
erythrocyte |
- |
655289, 712908 |
1.1.1.141 | 15-hydroxyprostaglandin dehydrogenase (NAD+) |
erythrocyte |
- |
285912 |
1.1.1.149 | 20alpha-hydroxysteroid dehydrogenase |
erythrocyte |
fetal |
285995 |
1.1.1.153 | sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming) |
erythrocyte |
- |
-, 286013, 286014, 286015, 286018, 286019, 286020, 286021, 286023, 286024 |
1.1.1.189 | prostaglandin-E2 9-reductase |
erythrocyte |
- |
389476 |
1.1.1.2 | alcohol dehydrogenase (NADP+) |
erythrocyte |
- |
286181, 286186 |
1.1.1.205 | IMP dehydrogenase |
erythrocyte |
- |
347965, 703272, 736152 |
1.1.1.205 | IMP dehydrogenase |
erythrocyte |
from healthy adults and paediatric patients on thiopurine therapy |
740801 |
1.1.1.205 | IMP dehydrogenase |
erythrocyte |
low activity |
736152 |
1.1.1.21 | aldose reductase |
erythrocyte |
- |
-, 286186, 286239, 655210, 669030, 700319, 712014, 713240, 721833, 722196 |
1.1.1.210 | 3beta(or 20alpha)-hydroxysteroid dehydrogenase |
erythrocyte |
fetal |
286265, 286266, 286267, 286268 |
1.1.1.27 | L-lactate dehydrogenase |
erythrocyte |
- |
740001 |
1.1.1.271 | GDP-L-fucose synthase |
erythrocyte |
- |
723814 |
1.1.1.30 | 3-hydroxybutyrate dehydrogenase |
erythrocyte |
- |
739558 |
1.1.1.37 | malate dehydrogenase |
erythrocyte |
- |
286635 |
1.1.1.43 | phosphogluconate 2-dehydrogenase |
erythrocyte |
- |
688050 |
1.1.1.44 | phosphogluconate dehydrogenase (NADP+-dependent, decarboxylating) |
erythrocyte |
- |
286834, 286836, 286837, 286838, 286839, 286841, 286849, 286850, 286881, 286890, 286892, 286895, 286897, 286903, 656386, 657143, 740635, 760750, 761410 |
1.1.1.49 | glucose-6-phosphate dehydrogenase (NADP+) |
erythrocyte |
- |
286984, 287002, 287004, 287009, 655712, 656382, 673169, 675104, 688050, 695426, 695960, 698392, 700590, 713131, 741459, 760750, 761410 |
1.1.1.51 | 3(or 17)beta-hydroxysteroid dehydrogenase |
erythrocyte |
- |
-, 287072, 287073 |
1.10.3.1 | catechol oxidase |
erythrocyte |
- |
684646 |
1.10.5.1 | ribosyldihydronicotinamide dehydrogenase (quinone) |
erythrocyte |
- |
659111 |
1.10.5.1 | ribosyldihydronicotinamide dehydrogenase (quinone) |
erythrocyte |
modest level |
657888 |
1.11.1.12 | phospholipid-hydroperoxide glutathione peroxidase |
erythrocyte |
- |
672372 |
1.11.1.2 | NADPH peroxidase |
erythrocyte |
- |
439812 |
1.11.1.24 | thioredoxin-dependent peroxiredoxin |
erythrocyte |
- |
655120, 657380, 684498, 687541, 695875 |
1.11.1.6 | catalase |
erythrocyte |
- |
439796, 439797, 439807, 439808, 684795, 698034, 710850 |
1.11.1.6 | catalase |
erythrocyte |
activities of catalase activity shows similar behavior after the exhaustive exercise bout, with a maximum activity at 3 h after the exercise. Activity tends to fall at 4 h after the exercise in comparison with 3 h |
677148 |
1.11.1.6 | catalase |
erythrocyte |
catalase activity increases with increasing blood lead level |
673930 |
1.11.1.6 | catalase |
erythrocyte |
enzyme activity is significantly lower in patients with Parkinsons disease compared to the control |
673975 |
1.11.1.6 | catalase |
erythrocyte |
pentylenetetrazol-induced epileptic seizure is accompanied by significantly reduced catalase activity |
673111 |
1.11.1.9 | glutathione peroxidase |
erythrocyte |
- |
396636, 658798, 684392, 687157, 688172, 701160, 764056 |
1.11.1.9 | glutathione peroxidase |
erythrocyte |
activity in erythrocytes from patients with non-small-cell lung cancer and small-cell lung cancer is slightly increased compared to healthy control group |
672886 |
1.13.11.33 | arachidonate 15-lipoxygenase |
erythrocyte |
immature |
742613 |
1.14.11.29 | hypoxia-inducible factor-proline dioxygenase |
erythrocyte |
- |
743285 |
1.14.11.67 | [histone H3]-trimethyl-L-lysine4 demethylase |
erythrocyte |
- |
765741 |
1.14.18.2 | CMP-N-acetylneuraminate monooxygenase |
erythrocyte |
- |
746206, 746215 |
1.15.1.1 | superoxide dismutase |
erythrocyte |
- |
-, 438089, 438097, 438098, 438122, 438125, 438128, 438129, 672084, 673801, 674931, 685849, 687064, 702175, 745059, 745763 |
1.15.1.1 | superoxide dismutase |
erythrocyte |
Cu,Zn-SOD |
-, 438165, 438174, 438181 |
1.15.1.1 | superoxide dismutase |
erythrocyte |
EC-SOD |
-, 438130 |
1.15.1.1 | superoxide dismutase |
erythrocyte |
isozyme Cu/Zn SOD |
714882 |
1.16.1.2 | diferric-transferrin reductase |
erythrocyte |
infected with Plasmodium falciparum, synthesis of the enzyme by the intraerythrocytic parasite |
440097 |
1.16.3.1 | ferroxidase |
erythrocyte |
- |
438014 |
1.17.3.2 | xanthine oxidase |
erythrocyte |
- |
744744 |
1.2.1.107 | glyceraldehyde-3-phosphate dehydrogenase (arsenate-transferring) |
erythrocyte |
- |
761413, 761416 |
1.2.1.12 | glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) |
erythrocyte |
- |
287900, 287910, 287932, 287945, 287950, 657393, 673629, 685025, 688250, 695298, 712640, 725592 |
1.2.1.23 | 2-oxoaldehyde dehydrogenase (NAD+) |
erythrocyte |
- |
288147 |
1.2.1.3 | aldehyde dehydrogenase (NAD+) |
erythrocyte |
- |
348683 |
1.2.1.36 | retinal dehydrogenase |
erythrocyte |
- |
655948, 691121 |
1.2.4.2 | oxoglutarate dehydrogenase (succinyl-transferring) |
erythrocyte |
- |
762857 |
1.20.4.1 | arsenate reductase (glutathione/glutaredoxin) |
erythrocyte |
- |
677207 |
1.3.3.3 | coproporphyrinogen oxidase |
erythrocyte |
- |
390944, 390945, 390950, 390958, 390972, 390973, 654965, 654966, 654975, 673243, 712835, 724548 |
1.4.3.5 | pyridoxal 5'-phosphate synthase |
erythrocyte |
- |
391879, 391893, 391894 |
1.5.1.2 | pyrroline-5-carboxylate reductase |
erythrocyte |
- |
392121 |
1.5.1.20 | methylenetetrahydrofolate reductase [NAD(P)H] |
erythrocyte |
- |
688565 |
1.5.1.30 | flavin reductase (NADPH) |
erythrocyte |
- |
392188, 714010, 714074, 714076, 765238 |
1.6.2.2 | cytochrome-b5 reductase |
erythrocyte |
- |
394239, 657460, 713204, 725046, 725047, 725721, 742321 |
1.6.2.2 | cytochrome-b5 reductase |
erythrocyte |
contains the soluble isozyme but no microsomal isozyme |
724801 |
1.6.2.2 | cytochrome-b5 reductase |
erythrocyte |
Cytb5r enzyme activity is drastically reduced in all patients with recessive hereditary methemoglobinemia. Eight different mutations are detected among the twelve mutated alleles identified |
685796 |
1.6.2.2 | cytochrome-b5 reductase |
erythrocyte |
nucleated |
725046 |
1.6.2.2 | cytochrome-b5 reductase |
erythrocyte |
soluble form |
392811, 394194, 394196, 394199, 394202, 394203, 394213, 394217, 394218, 394222, 394225 |
1.6.2.2 | cytochrome-b5 reductase |
erythrocyte |
transcript of R mRNA is detected |
394239 |
1.7.1.7 | GMP reductase |
erythrocyte |
- |
394287, 394290 |
1.8.1.7 | glutathione-disulfide reductase |
erythrocyte |
- |
394708, 394714, 394721, 394722, 394723, 394724, 394725, 394726, 394727, 394728, 394729, 394749, 394761, 394776, 438075, 659592, 659698, 659860, 660339, 671910, 673458, 688050, 696556, 696681, 699224, 699241, 699619, 699884, 700654, 711008, 724919, 725616 |
1.8.1.9 | thioredoxin-disulfide reductase |
erythrocyte |
genetic polymorphisms in the human selenoprotein P gene is associated with differences in thioredoxin reductase 1 concentrations |
686636 |
1.8.4.2 | protein-disulfide reductase (glutathione) |
erythrocyte |
- |
394810 |
1.8.5.1 | glutathione dehydrogenase (ascorbate) |
erythrocyte |
- |
394014, 394023, 394029 |
2.1.1.25 | phenol O-methyltransferase |
erythrocyte |
- |
485242 |
2.1.1.25 | phenol O-methyltransferase |
erythrocyte |
activity is lower in membranes from uremic patients on maintenance hemodialysis than in blood from randomly selected subjects |
485241 |
2.1.1.6 | catechol O-methyltransferase |
erythrocyte |
- |
441528, 733795 |
2.1.1.67 | thiopurine S-methyltransferase |
erythrocyte |
- |
485516, 485518, 485520, 485522, 485523, 485524, 485525, 485526, 485527, 657544, 659566, 685852, 685945, 686157, 686184, 686275, 686326, 686351, 686505, 686507, 686574, 687983, 689358, 689362, 689368, 689369, 690115, 690118, 702164, 702940, 703355, 704818, 704932, 705450, 706091, 706092, 706093, 706816, 718804, 733706, 733775, 734843, 755922, 756145, 756497, 757309, 757473 |
2.1.1.67 | thiopurine S-methyltransferase |
erythrocyte |
from patients with chronic inflammatory bowel disease |
658654 |
2.1.1.67 | thiopurine S-methyltransferase |
erythrocyte |
TPMT activity is significantly lower in patients with acute lymphoblastic leukemia compared to control. Increase of TPMT activity during maintainance treatment with 6-mercaptopurine and already after induction therapy (treatment with antifolates, e.g. methotrexate and trimethoprim), before the patients receive 6-mercaptopurine |
658653 |
2.1.1.67 | thiopurine S-methyltransferase |
erythrocyte |
TPMT phenotyping |
686161 |
2.1.1.71 | phosphatidyl-N-methylethanolamine N-methyltransferase |
erythrocyte |
- |
485555, 485560 |
2.1.1.71 | phosphatidyl-N-methylethanolamine N-methyltransferase |
erythrocyte |
present in red blood cells on the interior side of the membrane |
485555 |
2.1.1.77 | protein-L-isoaspartate(D-aspartate) O-methyltransferase |
erythrocyte |
- |
-, 485591, 485592, 485593, 485594, 485595, 485596, 485597, 485598, 485600, 485605, 485610, 485613, 485615, 485617, 702215 |
2.1.1.8 | histamine N-methyltransferase |
erythrocyte |
- |
441564, 701604 |
2.1.1.80 | protein-glutamate O-methyltransferase |
erythrocyte |
- |
485641 |
2.1.1.9 | thiol S-methyltransferase |
erythrocyte |
- |
441593, 441596 |
2.1.3.2 | aspartate carbamoyltransferase |
erythrocyte |
- |
485837 |
2.1.4.1 | glycine amidinotransferase |
erythrocyte |
- |
485965 |
2.2.1.1 | transketolase |
erythrocyte |
- |
486005, 486006, 486013, 486026, 692208, 692645 |
2.2.1.2 | transaldolase |
erythrocyte |
- |
486027 |
2.3.1.21 | carnitine O-palmitoyltransferase |
erythrocyte |
- |
486535 |
2.3.1.24 | sphingosine N-acyltransferase |
erythrocyte |
- |
754086 |
2.3.1.25 | plasmalogen synthase |
erythrocyte |
- |
486670 |
2.3.1.297 | very-long-chain ceramide synthase |
erythrocyte |
- |
754086 |
2.3.1.299 | sphingoid base N-stearoyltransferase |
erythrocyte |
- |
754086 |
2.3.1.37 | 5-aminolevulinate synthase |
erythrocyte |
- |
486820, 486850, 703095, 704690, 706627 |
2.3.1.37 | 5-aminolevulinate synthase |
erythrocyte |
enzyme in erythrocytes is genetically distinct from that in other tissue |
486808 |
2.3.1.37 | 5-aminolevulinate synthase |
erythrocyte |
Xalas2 is expressed in circulating erythrocytes |
735604 |
2.3.1.5 | arylamine N-acetyltransferase |
erythrocyte |
- |
686618 |
2.3.1.51 | 1-acylglycerol-3-phosphate O-acyltransferase |
erythrocyte |
mature |
487192 |
2.3.1.6 | choline O-acetyltransferase |
erythrocyte |
- |
686155 |
2.3.1.63 | 1-alkylglycerophosphocholine O-acyltransferase |
erythrocyte |
low activity |
487358 |
2.3.1.85 | fatty-acid synthase system |
erythrocyte |
- |
487569 |
2.3.2.13 | protein-glutamine gamma-glutamyltransferase |
erythrocyte |
- |
487823, 487824, 487825, 487828, 487832, 759166 |
2.3.2.13 | protein-glutamine gamma-glutamyltransferase |
erythrocyte |
ghosts |
487850 |
2.3.2.23 | E2 ubiquitin-conjugating enzyme |
erythrocyte |
- |
736063 |
2.3.2.B11 | ubiquitin transferase RING E3 (calmodulin-selective) |
erythrocyte |
- |
648930 |